{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:50:15Z","timestamp":1793407815001,"version":"4.5.0"},"publisher-location":"Cham","reference-count":287,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319042190","type":"print"},{"value":"9783319042206","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-3-319-04220-6_2","type":"book-chapter","created":{"date-parts":[[2014,4,5]],"date-time":"2014-04-05T00:28:44Z","timestamp":1396657724000},"page":"43-89","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":151,"title":["Epidemiology of Infections in Cancer Patients"],"prefix":"10.1007","author":[{"given":"Teresa R.","family":"Zembower","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,6]]},"reference":[{"issue":"3","key":"2_CR1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005792-197605000-00005","volume":"55","author":"HY Chang","year":"1976","unstructured":"Chang HY et al (1976) Causes of death in adults with acute leukemia. Medicine 55(3):259\u2013268 (Baltimore)","journal-title":"Medicine"},{"key":"2_CR2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1001\/jama.1965.03090020019005","volume":"193","author":"EM Hersh","year":"1965","unstructured":"Hersh EM et al (1965) Causes of death in acute leukemia: a ten-year study of 414 patients from 1954\u20131963. JAMA 193:105\u2013109","journal-title":"JAMA"},{"issue":"6","key":"2_CR3","first-page":"487","volume":"8","author":"J Homsi","year":"2000","unstructured":"Homsi J et al (2000) Infectious complications of advanced cancer. Support Care Cancer 8(6):487\u2013492","journal-title":"Support Care Cancer"},{"issue":"4","key":"2_CR4","first-page":"283","volume":"122","author":"WT Hughes","year":"1971","unstructured":"Hughes WT (1971) Fatal infections in childhood leukemia. Am J Dis Child 122(4):283\u2013287","journal-title":"Am J Dis Child"},{"issue":"2","key":"2_CR5","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/1097-0142(197402)33:2<568::AID-CNCR2820330236>3.0.CO;2-2","volume":"33","author":"J Inagaki","year":"1974","unstructured":"Inagaki J, Rodriguez V, Bodey GP (1974) Proceedings: causes of death in cancer patients. Cancer 33(2):568\u2013573","journal-title":"Cancer"},{"issue":"1","key":"2_CR6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/1097-0142(19820701)50:1<187::AID-CNCR2820500134>3.0.CO;2-Y","volume":"50","author":"JW Mayo","year":"1982","unstructured":"Mayo JW, Wenzel RP (1982) Rates of hospital-acquired bloodstream infections in patients with specific malignancy. Cancer 50(1):187\u2013190","journal-title":"Cancer"},{"issue":"2","key":"2_CR7","first-page":"135","volume":"76","author":"A Nosari","year":"1991","unstructured":"Nosari A et al (1991) Infections in haematologic neoplasms: autopsy findings. Haematologica 76(2):135\u2013140","journal-title":"Haematologica"},{"key":"2_CR8","first-page":"1","volume-title":"Infectious complications of cancer","author":"C Viscoli","year":"1995","unstructured":"Viscoli C, Castagnola E (1995) Factors predisposing cancer patients to infection. In: Klastersky K (ed) Infectious complications of cancer. Kluwer Academic, Boston, pp 1\u201330"},{"issue":"5","key":"2_CR9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/bjc.1989.167","volume":"59","author":"L Morittu","year":"1989","unstructured":"Morittu L et al (1989) Patients at risk of chemotherapy-associated toxicity in small cell lung cancer. Br J Cancer 59(5):801\u2013804","journal-title":"Br J Cancer"},{"key":"2_CR10","unstructured":"Freifeld AG, Kaul DR (2008) Infection in the patient with cancer, in Abeloff\u2019s clinical oncology. In: Abeloff MD et al (eds) Churchill Livingstone, Philadelphia, pp 717\u2013738"},{"key":"2_CR11","unstructured":"Viscoli C, Castagnola E (2009) Prophylaxis and empirical therapy of infection in cancer patients. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Doublas, and Bennett\u2019s principle and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp 3793-3808"},{"key":"2_CR12","unstructured":"Donnelly JP, Blijlevens NMA, De Pauw BE (2009) Infections in the immunocompromised host: general principles. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp 3781\u20133792"},{"key":"2_CR13","unstructured":"Vusirikala M (2009) Supportive care in hematologic malignancies, in Wintrobe\u2019s clinical hematology. In: Greer JP et al (ed) Lippincott Williams and Wilkins, Philadelphia, pp 1747\u20131790"},{"issue":"3","key":"2_CR14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijantimicag.2007.06.014","volume":"31","author":"G Maschmeyer","year":"2008","unstructured":"Maschmeyer G, Haas A (2008) The epidemiology and treatment of infections in cancer patients. Int J Antimicrob Agents 31(3):193\u2013197","journal-title":"Int J Antimicrob Agents"},{"key":"2_CR15","unstructured":"Todar K (2008) Immune defense against bacterial pathogens: innate immunity. In: Todar K (ed) Todar\u2019s online textbook of bacteriology"},{"key":"2_CR16","unstructured":"Todar K (2008) Immune defense against bacterial pathogens: adaptive or acquired immunity. In Todar K (ed) Todar\u2019s online textbook of bacteriology"},{"key":"2_CR17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-4613-1239-0_3","volume":"79","author":"JP Donnelly","year":"1995","unstructured":"Donnelly JP (1995) Chemoprophylaxis for the prevention of bacterial and fungal infections. Cancer Treat Res 79:45\u201381","journal-title":"Cancer Treat Res"},{"key":"2_CR18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.mi.42.100188.002301","volume":"42","author":"RR Roth","year":"1988","unstructured":"Roth RR, James WD (1988) Microbial ecology of the skin. Annu Rev Microbiol 42:441\u2013464","journal-title":"Annu Rev Microbiol"},{"issue":"2","key":"2_CR19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/QCO.0b013e328335b004","volume":"23","author":"JM Schroder","year":"2010","unstructured":"Schroder JM (2010) The role of keratinocytes in defense against infection. Curr Opin Infect Dis 23(2):106\u2013110","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"2_CR20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/clinids\/15.1.33","volume":"15","author":"A Awada","year":"1992","unstructured":"Awada A et al (1992) Streptococcal and enterococcal bacteremia in patients with cancer. Clin Infect Dis 15(1):33\u201348","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2_CR21","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jama.1992.03480100060031","volume":"267","author":"PI Axelrod","year":"1992","unstructured":"Axelrod PI, Lorber B, Vonderheid EC (1992) Infections complicating mycosis fungoides and Sezary syndrome. JAMA 267(10):1354\u20131358","journal-title":"JAMA"},{"key":"2_CR22","unstructured":"Glauser MP, Zinner SH (1982) Mechanisms of acquisition and development of bacterial infections in cancer patients. In: Klastersky J (ed) Infections in cancer patients. Raven Press, New York, pp 13\u201330"},{"issue":"4","key":"2_CR23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1067\/mjd.2003.87","volume":"48","author":"VC Hall","year":"2003","unstructured":"Hall VC et al (2003) Dermatologic side effects of thalidomide in patients with multiple myeloma. J Am Acad Dermatol 48(4):548\u2013552","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2_CR24","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0022-3476(99)70064-8","volume":"135","author":"SE Dorman","year":"1999","unstructured":"Dorman SE et al (1999) Viral infections in interferon-gamma receptor deficiency. J Pediatr 135(5):640\u2013643","journal-title":"J Pediatr"},{"key":"2_CR25","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0002-9343(63)90140-2","volume":"35","author":"JL Fahey","year":"1963","unstructured":"Fahey JL et al (1963) Infection, antibody response and gamma globulin components in multiple myeloma and macroglobulinemia. Am J Med 35:698\u2013707","journal-title":"Am J Med"},{"issue":"Pt 1","key":"2_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.18709-0","volume":"84","author":"HW Favoreel","year":"2003","unstructured":"Favoreel HW et al (2003) Virus complement evasion strategies. J Gen Virol 84(Pt 1):1\u201315","journal-title":"J Gen Virol"},{"issue":"2","key":"2_CR27","first-page":"135","volume":"10","author":"SE Salmon","year":"1973","unstructured":"Salmon SE (1973) Immunoglobulin synthesis and tumor kinetics of multiple myeloma. Semin Hematol 10(2):135\u2013144","journal-title":"Semin Hematol"},{"issue":"7","key":"2_CR28","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1182\/blood.V75.7.1583.1583","volume":"75","author":"JF Sheridan","year":"1990","unstructured":"Sheridan JF et al (1990) Immunoglobulin G subclass deficiency and pneumococcal infection after allogeneic bone marrow transplantation. Blood 75(7):1583\u20131586","journal-title":"Blood"},{"key":"2_CR29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1128\/MMBR.27.1.72-86.1963","volume":"27","author":"RR Wagner","year":"1963","unstructured":"Wagner RR (1963) Cellular resistance to viral infection, with particular reference to endogenous interferon. Bacteriol Rev 27:72\u201386","journal-title":"Bacteriol Rev"},{"issue":"12","key":"2_CR30","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJM198803243181205","volume":"318","author":"RB Johnston Jr","year":"1988","unstructured":"Johnston RB Jr (1988) Current concepts: immunology. Monocytes and macrophages. N Engl J Med 318(12):747\u2013752","journal-title":"N Engl J Med"},{"issue":"4","key":"2_CR31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nchembio.1186","volume":"9","author":"S Barbuto","year":"2013","unstructured":"Barbuto S et al (2013) Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells. Nat Chem Biol 9(4):250\u2013256","journal-title":"Nat Chem Biol"},{"key":"2_CR32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-4684-5535-9_4","volume":"237","author":"RM Steinman","year":"1988","unstructured":"Steinman RM, Inaba K (1988) The binding of antigen presenting cells to T lymphocytes. Adv Exp Med Biol 237:31\u201341","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"2_CR33","doi-asserted-by":"crossref","first-page":"e1002619","DOI":"10.1371\/journal.ppat.1002619","volume":"8","author":"M Urb","year":"2012","unstructured":"Urb M, Sheppard DC (2012) The role of mast cells in the defence against pathogens. PLoS Pathog 8(4):e1002619","journal-title":"PLoS Pathog"},{"issue":"2","key":"2_CR34","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/IAI.00953-12","volume":"81","author":"LJ Hall","year":"2013","unstructured":"Hall LJ et al (2013) Natural killer cells protect against mucosal and systemic infection with the enteric pathogen Citrobacter rodentium. Infect Immun 81(2):460\u2013469","journal-title":"Infect Immun"},{"key":"2_CR35","first-page":"88","volume":"2","author":"A Horowitz","year":"2011","unstructured":"Horowitz A, Stegmann KA, Riley EM (2011) Activation of natural killer cells during microbial infections. Front Immunol 2:88","journal-title":"Front Immunol"},{"key":"2_CR36","doi-asserted-by":"crossref","first-page":"152430","DOI":"10.1155\/2011\/152430","volume":"2011","author":"F Marras","year":"2011","unstructured":"Marras F, Bozzano F, De Maria A (2011) Involvement of activating NK cell receptors and their modulation in pathogen immunity. J Biomed Biotechnol 2011:152430","journal-title":"J Biomed Biotechnol"},{"issue":"6","key":"2_CR37","first-page":"1017","volume":"75","author":"EH Steinhauer","year":"1985","unstructured":"Steinhauer EH et al (1985) Natural killer cytotoxic factor induction by K562 cells in patients with advanced cancer: correlation with production of interferon. J Natl Cancer Inst 75(6):1017\u20131023","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2_CR38","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","volume":"64","author":"GP Bodey","year":"1966","unstructured":"Bodey GP et al (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64(2):328\u2013340","journal-title":"Ann Intern Med"},{"issue":"3","key":"2_CR39","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/1097-0142(197703)39:3<1018::AID-CNCR2820390304>3.0.CO;2-N","volume":"39","author":"R Feld","year":"1977","unstructured":"Feld R, Bodey GP (1977) Infections in patients with malignant lymphoma treated with combination chemotherapy. Cancer 39(3):1018\u20131025","journal-title":"Cancer"},{"issue":"4","key":"2_CR40","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52(4):e56\u2013e93","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2_CR41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/j.seminhematol.2009.03.008","volume":"46","author":"JM Valdez","year":"2009","unstructured":"Valdez JM et al (2009) Infections in patients with aplastic anemia. Semin Hematol 46(3):269\u2013276","journal-title":"Semin Hematol"},{"issue":"1","key":"2_CR42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/infdis\/137.1.14","volume":"137","author":"SC Schimpff","year":"1978","unstructured":"Schimpff SC et al (1978) Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group. J Infect Dis 137(1):14\u201329","journal-title":"J Infect Dis"},{"issue":"6","key":"2_CR43","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1084\/jem.136.6.1631","volume":"136","author":"WH Brooks","year":"1972","unstructured":"Brooks WH et al (1972) Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med 136(6):1631\u20131647","journal-title":"J Exp Med"},{"issue":"3","key":"2_CR44","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/1097-0142(197209)30:3<616::AID-CNCR2820300304>3.0.CO;2-Q","volume":"30","author":"T Han","year":"1972","unstructured":"Han T, Takita H (1972) Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin. Cancer 30(3):616\u2013620","journal-title":"Cancer"},{"issue":"2","key":"2_CR45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0308-2261(21)00026-6","volume":"5","author":"JA Krick","year":"1976","unstructured":"Krick JA, Remington JS (1976) Opportunistic invasive fungal infections in patients with leukaemia lymphoma. Clin Haematol 5(2):249\u2013310","journal-title":"Clin Haematol"},{"issue":"3","key":"2_CR46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0889-8588(18)30484-2","volume":"4","author":"LG Lum","year":"1990","unstructured":"Lum LG (1990) Immune recovery after bone marrow transplantation. Hematol Oncol Clin North Am 4(3):659\u2013675","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"2_CR47","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/1097-0142(197612)38:6<2343::AID-CNCR2820380621>3.0.CO;2-T","volume":"38","author":"K Orita","year":"1976","unstructured":"Orita K et al (1976) Preoperative cell-mediated immune status of gastric cancer patients. Cancer 38(6):2343\u20132348","journal-title":"Cancer"},{"issue":"1","key":"2_CR48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/1097-0142(197607)38:1<149::AID-CNCR2820380124>3.0.CO;2-Q","volume":"38","author":"PF Schellhammer","year":"1976","unstructured":"Schellhammer PF et al (1976) Immune evaluation with skin testing. A study of testicular, prostatic, and bladder neoplasms. Cancer 38(1):149\u2013156","journal-title":"Cancer"},{"issue":"20","key":"2_CR49","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM198411153112005","volume":"311","author":"M Seligmann","year":"1984","unstructured":"Seligmann M et al (1984) AIDS\u2013an immunologic reevaluation. N Engl J Med 311(20):1286\u20131292","journal-title":"N Engl J Med"},{"issue":"7705","key":"2_CR50","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0140-6736(71)92448-2","volume":"1","author":"MG Whittaker","year":"1971","unstructured":"Whittaker MG, Rees K, Clark CG (1971) Reduced lymphocyte transformation in breast cancer. Lancet 1(7705):892\u2013893","journal-title":"Lancet"},{"issue":"1","key":"2_CR51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0002-9343(72)90008-3","volume":"52","author":"RC Young","year":"1972","unstructured":"Young RC et al (1972) Delayed hypersensitivity in Hodgkin\u2019s disease. A study of 103 untreated patients. Am J Med 52(1):63\u201372","journal-title":"Am J Med"},{"issue":"5","key":"2_CR52","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/clinids\/11.5.677","volume":"11","author":"JH Kim","year":"1989","unstructured":"Kim JH, Perfect JR (1989) Infection and cyclosporine. Rev Infect Dis 11(5):677\u2013690","journal-title":"Rev Infect Dis"},{"issue":"3","key":"2_CR53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJM199501193320303","volume":"332","author":"CL Mackall","year":"1995","unstructured":"Mackall CL et al (1995) Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 332(3):143\u2013149","journal-title":"N Engl J Med"},{"issue":"7","key":"2_CR54","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1182\/blood.V84.7.2221.2221","volume":"84","author":"CL Mackall","year":"1994","unstructured":"Mackall CL et al (1994) Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 84(7):2221\u20132228","journal-title":"Blood"},{"issue":"5","key":"2_CR55","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7326\/0003-4819-95-5-549","volume":"95","author":"JF Bishop","year":"1981","unstructured":"Bishop JF et al (1981) Infections during intensive chemotherapy for non-Hodgkin\u2019s lymphoma. Ann Intern Med 95(5):549\u2013555","journal-title":"Ann Intern Med"},{"issue":"2","key":"2_CR56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0305-7372(86)90015-0","volume":"13","author":"MA Bookman","year":"1986","unstructured":"Bookman MA, Longo DL (1986) Concomitant illness in patients treated for Hodgkin\u2019s disease. Cancer Treat Rev 13(2):77\u2013111","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"2_CR57","doi-asserted-by":"crossref","first-page":"615","DOI":"10.7326\/0003-4819-100-4-615_3","volume":"100","author":"JC Chan","year":"1984","unstructured":"Chan JC, Hensley GT, Moskowitz LB (1984) Toxoplasmosis in the central nervous system. Ann Intern Med 100(4):615\u2013616","journal-title":"Ann Intern Med"},{"issue":"22","key":"2_CR58","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJM199111283252204","volume":"325","author":"I Hardy","year":"1991","unstructured":"Hardy I et al (1991) The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med 325(22):1545\u20131550","journal-title":"N Engl J Med"},{"issue":"6","key":"2_CR59","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/cncr.2820360912","volume":"36","author":"WT Hughes","year":"1975","unstructured":"Hughes WT et al (1975) Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis. Cancer 36(6):2004\u20132009","journal-title":"Cancer"},{"issue":"2","key":"2_CR60","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0002-9343(81)90781-6","volume":"70","author":"WT Hughes","year":"1981","unstructured":"Hughes WT, Townsend TR (1981) Nosocomial infections in immunocompromised children. Am J Med 70(2):412\u2013416","journal-title":"Am J Med"},{"issue":"1","key":"2_CR61","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/CMR.17.1.208-217.2004","volume":"17","author":"PB Keiser","year":"2004","unstructured":"Keiser PB, Nutman TB (2004) Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 17(1):208\u2013217","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 2","key":"2_CR62","doi-asserted-by":"crossref","first-page":"S416","DOI":"10.1093\/clinids\/17.Supplement_2.S416","volume":"17","author":"KA Sepkowitz","year":"1993","unstructured":"Sepkowitz KA (1993) Pneumocystis carinii pneumonia in patients without AIDS. Clin Infect Dis 17(Suppl 2):S416\u2013S422","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2_CR63","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jama.1992.03480060078034","volume":"267","author":"KA Sepkowitz","year":"1992","unstructured":"Sepkowitz KA et al (1992) Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 267(6):832\u2013837","journal-title":"JAMA"},{"issue":"4","key":"2_CR64","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0305-7372(93)90011-F","volume":"19","author":"I Varthalitis","year":"1993","unstructured":"Varthalitis I, Meunier F (1993) Pneumocystis carinii pneumonia in cancer patients. Cancer Treat Rev 19(4):387\u2013413","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"2_CR65","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM198101293040501","volume":"304","author":"SW Hosea","year":"1981","unstructured":"Hosea SW et al (1981) Opsonic requirements for intravascular clearance after splenectomy. N Engl J Med 304(5):245\u2013450","journal-title":"N Engl J Med"},{"key":"2_CR66","unstructured":"Van Der Meer JWM (1988) Defects in host-defense mechanisms. In: Rubin RH, Young LS (eds) Clinical approach to infection in the compromised host. Plenum Medical, New York, pp 41\u201363"},{"issue":"25","key":"2_CR67","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM198606193142501","volume":"314","author":"MH Gaston","year":"1986","unstructured":"Gaston MH et al (1986) Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 314(25):1593\u20131599","journal-title":"N Engl J Med"},{"issue":"7","key":"2_CR68","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0022-3468(99)90565-1","volume":"34","author":"M Jugenburg","year":"1999","unstructured":"Jugenburg M et al (1999) The morbidity and mortality of pediatric splenectomy: does prophylaxis make a difference? J Pediatr Surg 34(7):1064\u20131067","journal-title":"J Pediatr Surg"},{"issue":"2","key":"2_CR69","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2141.1999.01373.x","volume":"105","author":"RD Keenan","year":"1999","unstructured":"Keenan RD, Boswell T, Milligan DW (1999) Do post-splenectomy patients take prophylactic penicillin? Br J Haematol 105(2):509\u2013510","journal-title":"Br J Haematol"},{"issue":"1","key":"2_CR70","first-page":"9","volume":"62","author":"Group, A.A.I.W., et al","year":"2013","unstructured":"Group, A.A.I.W. et al (2013) Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for adults aged 19\u00a0years and older\u2014United States, 2013. MMWR Surveill Summ 62(1):9\u201319","journal-title":"MMWR Surveill Summ"},{"issue":"l","key":"2_CR71","first-page":"2","volume":"62","author":"A.C.A.I.W. Group","year":"2013","unstructured":"Group A.C.A.I.W. et al (2013) Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for persons aged 0 through 18\u00a0years\u2013United States. MMWR Surveill Summ 62(l):2\u20138","journal-title":"MMWR Surveill Summ"},{"key":"2_CR72","unstructured":"Schimpff SC (1995) Infection in the cancer patient\u2013diagnosis, prevention, and treatment. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases. Churchill Livingstone, New York, pp 2666\u20132675"},{"issue":"3","key":"2_CR73","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.diabet.2012.01.002","volume":"38","author":"B Rammaert","year":"2012","unstructured":"Rammaert B et al (2012) Diabetes and mucormycosis: a complex interplay. Diabetes Metab 38(3):193\u2013204","journal-title":"Diabetes Metab"},{"issue":"6","key":"2_CR74","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s00125-012-2526-0","volume":"55","author":"AG Renehan","year":"2012","unstructured":"Renehan AG et al (2012) Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer. Diabetologia 55(6):1619\u20131632","journal-title":"Diabetologia"},{"issue":"23","key":"2_CR75","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1001\/jama.2008.824","volume":"300","author":"BB Barone","year":"2008","unstructured":"Barone BB et al (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300(23):2754\u20132764","journal-title":"JAMA"},{"issue":"4","key":"2_CR76","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/dc09-1721","volume":"33","author":"BB Barone","year":"2010","unstructured":"Barone BB et al (2010) Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis. Diabetes Care 33(4):931\u2013939","journal-title":"Diabetes Care"},{"issue":"4","key":"2_CR77","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0002-9343(89)80836-8","volume":"87","author":"AL Daly","year":"1989","unstructured":"Daly AL et al (1989) Mucormycosis: association with deferoxamine therapy. Am J Med 87(4):468\u2013471","journal-title":"Am J Med"},{"issue":"2","key":"2_CR78","first-page":"207","volume":"89","author":"L Pagano","year":"2004","unstructured":"Pagano L et al (2004) Mucormycosis in hematologic patients. Haematologica 89(2):207\u2013214","journal-title":"Haematologica"},{"issue":"1","key":"2_CR79","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jss.2010.03.063","volume":"163","author":"CJ Balentine","year":"2010","unstructured":"Balentine CJ et al (2010) Obese patients benefit from minimally invasive colorectal cancer surgery. J Surg Res 163(1):29\u201334","journal-title":"J Surg Res"},{"issue":"1","key":"2_CR80","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jamcollsurg.2008.08.032","volume":"208","author":"RP Merkow","year":"2009","unstructured":"Merkow RP et al (2009) Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg 208(1):53\u201361","journal-title":"J Am Coll Surg"},{"issue":"12","key":"2_CR81","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s10350-008-9395-0","volume":"51","author":"S Tsujinaka","year":"2008","unstructured":"Tsujinaka S et al (2008) Visceral obesity predicts surgical outcomes after laparoscopic colectomy for sigmoid colon cancer. Dis Colon Rectum 51(12):1757\u20131765; discussion 1765\u20131767","journal-title":"Dis Colon Rectum"},{"key":"2_CR82","doi-asserted-by":"crossref","unstructured":"Safdar A, Bodey G, Armstrong D (2011) Infections in patients with cancer: overview. In: S. A (ed) Principles and practice of cancer infectious diseases. Springer, New York, pp 3\u201316","DOI":"10.1007\/978-1-60761-644-3_1"},{"issue":"1","key":"2_CR83","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/clinids\/17.1.109","volume":"17","author":"A Anand","year":"1993","unstructured":"Anand A, Glatt AE (1993) Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis 17(1):109\u2013113","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2_CR84","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/jhin.2002.1356","volume":"53","author":"E Blot","year":"2003","unstructured":"Blot E et al (2003) Outbreak of Clostridium difficile-related diarrhoea in an adult oncology unit: risk factors and microbiological characteristics. J Hosp Infect 53(3):187\u2013192","journal-title":"J Hosp Infect"},{"issue":"10","key":"2_CR85","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1586\/eri.10.95","volume":"8","author":"T Chopra","year":"2010","unstructured":"Chopra T, Alangaden GJ, Chandrasekar P (2010) Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients. Expert Rev Anti Infect Ther 8(10):1113\u20131119","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"8","key":"2_CR86","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1086\/502602","volume":"26","author":"TN Palmore","year":"2005","unstructured":"Palmore TN et al (2005) Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital. Infect Control Hosp Epidemiol 26(8):680\u2013684","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"2_CR87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157489110790112608","volume":"5","author":"S Raza","year":"2010","unstructured":"Raza S et al (2010) Clostridium difficile infection following chemotherapy. Recent Pat Antiinfect Drug Discov 5(1):1\u20139","journal-title":"Recent Pat Antiinfect Drug Discov"},{"issue":"6","key":"2_CR88","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1525-1438.1999.99065.x","volume":"9","author":"E Resnik","year":"1999","unstructured":"Resnik E, Lefevre CA (1999) Fulminant Clostridium difficile colitis associated with paclitaxel and carboplatin chemotherapy. Int J Gynecol Cancer 9(6):512\u2013514","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"2_CR89","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s11605-012-1930-6","volume":"16","author":"DB Stewart","year":"2012","unstructured":"Stewart DB, Yacoub E, Zhu J (2012) Chemotherapy patients with C. difficile colitis have outcomes similar to immunocompetent C. difficile patients. J Gastrointest Surg 16(8):1566\u20131572","journal-title":"J Gastrointest Surg"},{"key":"2_CR90","unstructured":"National Cancer Institute (2009) Nutrition in cancer care (PDQ) health professional version. 30 Dec 2009. Available from http:\/\/www.cancer.gov\/cancertopics\/pdq\/supportivecare\/nutrition\/HealthProfessional\/page1 . Last accessed 18 Aug 2013"},{"issue":"4","key":"2_CR91","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/MCO.0b013e3281e2c983","volume":"10","author":"MM Marin Caro","year":"2007","unstructured":"Marin Caro MM, Laviano A, Pichard C (2007) Impact of nutrition on quality of life during cancer. Curr Opin Clin Nutr Metab Care 10(4):480\u2013487","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"6","key":"2_CR92","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/sj.bjc.6605578","volume":"102","author":"M Pressoir","year":"2010","unstructured":"Pressoir M et al (2010) Prevalence, risk factors and clinical implications of malnutrition in French comprehensive cancer centres. Br J Cancer 102(6):966\u2013971","journal-title":"Br J Cancer"},{"issue":"3","key":"2_CR93","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0749-0704(05)70206-2","volume":"17","author":"PW Wong","year":"2001","unstructured":"Wong PW, Enriquez A, Barrera R (2001) Nutritional support in critically ill patients with cancer. Crit Care Clin 17(3):743\u2013767","journal-title":"Crit Care Clin"},{"issue":"12","key":"2_CR94","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00595-006-3320-8","volume":"36","author":"H Horie","year":"2006","unstructured":"Horie H et al (2006) Favorable effects of preoperative enteral immunonutrition on a surgical site infection in patients with colorectal cancer without malnutrition. Surg Today 36(12):1063\u20131068","journal-title":"Surg Today"},{"issue":"8","key":"2_CR95","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/jama.286.8.944","volume":"286","author":"DK Heyland","year":"2001","unstructured":"Heyland DK et al (2001) Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 286(8):944\u2013953","journal-title":"JAMA"},{"issue":"4","key":"2_CR96","first-page":"418","volume":"30","author":"JB Celik","year":"2009","unstructured":"Celik JB et al (2009) The role of immunonutrition in gynecologic oncologic surgery. Eur J Gynaecol Oncol 30(4):418\u2013421","journal-title":"Eur J Gynaecol Oncol"},{"issue":"6","key":"2_CR97","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/00007890-198743060-00012","volume":"43","author":"SA Weisdorf","year":"1987","unstructured":"Weisdorf SA et al (1987) Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation 43(6):833\u2013838","journal-title":"Transplantation"},{"issue":"2\u20133","key":"2_CR98","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0278-5846(87)90051-0","volume":"11","author":"J Irwin","year":"1987","unstructured":"Irwin J, Livnat S (1987) Behavioral influences on the immune system: stress and conditioning. Prog Neuropsychopharmacol Biol Psychiatry 11(2\u20133):137\u2013143","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4\u20135","key":"2_CR99","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0031-9384(02)00923-X","volume":"77","author":"AL Marsland","year":"2002","unstructured":"Marsland AL et al (2002) Stress, immune reactivity and susceptibility to infectious disease. Physiol Behav 77(4\u20135):711\u2013716","journal-title":"Physiol Behav"},{"issue":"2","key":"2_CR100","first-page":"141","volume":"14","author":"ME Falagas","year":"2010","unstructured":"Falagas ME et al (2010) Psychosocial factors and susceptibility to or outcome of acute respiratory tract infections. Int J Tuberc Lung Dis 14(2):141\u2013148","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"2_CR101","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.bbi.2007.07.010","volume":"21","author":"ME Kemeny","year":"2007","unstructured":"Kemeny ME, Schedlowski M (2007) Understanding the interaction between psychosocial stress and immune-related diseases: a stepwise progression. Brain Behav Immun 21(8):1009\u20131018","journal-title":"Brain Behav Immun"},{"issue":"2","key":"2_CR102","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/187221308784543647","volume":"2","author":"A Aubert","year":"2008","unstructured":"Aubert A (2008) Psychosocial stress, emotions and cytokine-related disorders. Recent Pat Inflamm Allergy Drug Discov 2(2):139\u2013148","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"issue":"10","key":"2_CR103","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1470-2045(04)01597-9","volume":"5","author":"EM Reiche","year":"2004","unstructured":"Reiche EM, Nunes SO, Morimoto HK (2004) Stress, depression, the immune system, and cancer. Lancet Oncol 5(10):617\u2013625","journal-title":"Lancet Oncol"},{"issue":"5","key":"2_CR104","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/SLA.0b013e3181dae4ed","volume":"251","author":"BC Paun","year":"2010","unstructured":"Paun BC et al (2010) Postoperative complications following surgery for rectal cancer. Ann Surg 251(5):807\u2013818","journal-title":"Ann Surg"},{"issue":"3","key":"2_CR105","first-page":"329","volume":"139","author":"BD Wilson","year":"1974","unstructured":"Wilson BD, Surgalla MJ, Yates JW (1974) Aerobic and anaerobic surgical wound contamination in patients with cancer. Surg Gynecol Obstet 139(3):329\u2013332","journal-title":"Surg Gynecol Obstet"},{"issue":"7","key":"2_CR106","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1245\/ASO.2003.07.023","volume":"10","author":"CD Morris","year":"2003","unstructured":"Morris CD et al (2003) Prospective identification of risk factors for wound infection after lower extremity oncologic surgery. Ann Surg Oncol 10(7):778\u2013782","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2_CR107","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00000658-197307000-00006","volume":"178","author":"RD Gongaware","year":"1973","unstructured":"Gongaware RD, Slanetz CA Jr (1973) Hartmann procedure for carcinoma of the sigmoid and rectum. Ann Surg 178(1):28\u201330","journal-title":"Ann Surg"},{"issue":"5","key":"2_CR108","first-page":"810","volume":"137","author":"H Naito","year":"1973","unstructured":"Naito H et al (1973) High incidence of acute postoperative meningitis and septicemia in patients undergoing craniotomy with ventriculoatrial shunt. Surg Gynecol Obstet 137(5):810\u2013812","journal-title":"Surg Gynecol Obstet"},{"issue":"4","key":"2_CR109","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jso.2930050412","volume":"5","author":"GW Geelhoed","year":"1973","unstructured":"Geelhoed GW, Ketcham AS (1973) Pseudomonas meningitis complicating radical resection for radiorecurrent cancer of the paranasal sinuses: report of two patients successfully treated with intrathecal polymyxin. J Surg Oncol 5(4):365\u2013374","journal-title":"J Surg Oncol"},{"issue":"35","key":"2_CR110","first-page":"1927","volume":"29","author":"D Lefebvre","year":"2000","unstructured":"Lefebvre D et al (2000) Incidence and surgical wound infection risk factors in breast cancer surgery. Presse Med 29(35):1927\u20131932","journal-title":"Presse Med"},{"issue":"3","key":"2_CR111","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00268-003-7193-3","volume":"28","author":"D Vilar-Compte","year":"2004","unstructured":"Vilar-Compte D et al (2004) Surgical site infections in breast surgery: case-control study. World J Surg 28(3):242\u2013246","journal-title":"World J Surg"},{"issue":"Suppl 2","key":"2_CR112","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1089\/sur.2006.7.s2-5","volume":"7","author":"RS Accolla","year":"2006","unstructured":"Accolla RS (2006) Host defense mechanisms against pathogens. Surg Infect 7(Suppl 2):S5\u2013S7 (Larchmt)","journal-title":"Surg Infect"},{"issue":"12","key":"2_CR113","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s00595-009-4011-z","volume":"39","author":"T Nakamura","year":"2009","unstructured":"Nakamura T et al (2009) Retrospective, matched case-control study comparing the oncologic outcomes between laparoscopic surgery and open surgery in patients with right-sided colon cancer. Surg Today 39(12):1040\u20131045","journal-title":"Surg Today"},{"issue":"3","key":"2_CR114","first-page":"217","volume":"165","author":"HV Villar","year":"1987","unstructured":"Villar HV et al (1987) Role of surgical treatment in the management of complications of the gastrointestinal tract in patients with leukemia. Surg Gynecol Obstet 165(3):217\u2013222","journal-title":"Surg Gynecol Obstet"},{"issue":"1","key":"2_CR115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/1097-0142(19920101)69:1<17::AID-CNCR2820690106>3.0.CO;2-X","volume":"69","author":"DS Wade","year":"1992","unstructured":"Wade DS, Nava HR, Douglass HO Jr (1992) Neutropenic enterocolitis. Clinical diagnosis and treatment. Cancer 69(1):17\u201323","journal-title":"Cancer"},{"issue":"3","key":"2_CR116","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/sur.2008.061","volume":"10","author":"BW Ullery","year":"2009","unstructured":"Ullery BW et al (2009) Neutropenic enterocolitis. Surg Infect 10(3):307\u2013314 (Larchmt)","journal-title":"Surg Infect"},{"issue":"3","key":"2_CR117","first-page":"370","volume":"138","author":"CC Say","year":"1974","unstructured":"Say CC, Donegan W (1974) A biostatistical evaluation of complications from mastectomy. Surg Gynecol Obstet 138(3):370\u2013376","journal-title":"Surg Gynecol Obstet"},{"issue":"5799","key":"2_CR118","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/bmj.1.5799.527","volume":"1","author":"MG Smith","year":"1972","unstructured":"Smith MG et al (1972) Cell-mediated immune responses in chronic liver diseases. Br Med J 1(5799):527\u2013530","journal-title":"Br Med J"},{"issue":"3","key":"2_CR119","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00004347-198303000-00007","volume":"2","author":"DM Lowell","year":"1983","unstructured":"Lowell DM, LiVolsi VA, Ludwig ME (1983) Genital condyloma virus infection following pelvic radiation therapy: report of seven cases. Int J Gynecol Pathol 2(3):294\u2013302","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"2_CR120","first-page":"209","volume":"30","author":"M Caloglu","year":"2007","unstructured":"Caloglu M et al (2007) An ambiguous phenomenon of radiation and drugs: recall reactions. Onkologie 30(4):209\u2013214","journal-title":"Onkologie"},{"issue":"3","key":"2_CR121","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0167-8140(01)00328-0","volume":"59","author":"R Camidge","year":"2001","unstructured":"Camidge R, Price A (2001) Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol 59(3):237\u2013245","journal-title":"Radiother Oncol"},{"issue":"3","key":"2_CR122","doi-asserted-by":"crossref","first-page":"294","DOI":"10.7326\/0003-4819-85-3-294","volume":"85","author":"FA Greco","year":"1976","unstructured":"Greco FA et al (1976) Adriamycin and enhanced radiation reaction in normal esophagus and skin. Ann Intern Med 85(3):294\u2013298","journal-title":"Ann Intern Med"},{"issue":"6","key":"2_CR123","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/120347540200600603","volume":"6","author":"KJ Smith","year":"2002","unstructured":"Smith KJ, Germain M, Skelton H (2002) Histopathologic features seen with radiation recall or enhancement eruptions. J Cutan Med Surg 6(6):535\u2013540","journal-title":"J Cutan Med Surg"},{"key":"2_CR124","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1752-1947-3-93","volume":"3","author":"C Spirig","year":"2009","unstructured":"Spirig C et al (2009) Radiation recall dermatitis with soft tissue necrosis following pemetrexed therapy: a case report. J Med Case Rep 3:93","journal-title":"J Med Case Rep"},{"issue":"lC","key":"2_CR125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jac\/21.suppl_C.149","volume":"21","author":"C Viscoli","year":"1988","unstructured":"Viscoli C, Van der Auwera P, Meunier F (1988) Gram-positive infections in granulocytopenic patients: an important issue? J Antimicrob Chemother 21(lC):149\u201356","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"2_CR126","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00262-008-0576-4","volume":"58","author":"CN Baxevanis","year":"2009","unstructured":"Baxevanis CN, Perez SA, Papamichail M (2009) Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy. Cancer Immunol Immunother 58(3):317\u2013324","journal-title":"Cancer Immunol Immunother"},{"issue":"15","key":"2_CR127","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/ajhp\/60.15.1531","volume":"60","author":"RJ Cersosimo","year":"2003","unstructured":"Cersosimo RJ (2003) Monoclonal antibodies in the treatment of cancer. Part 1 Am J Health Syst Pharm 60(15):1531\u20131548","journal-title":"Part 1 Am J Health Syst Pharm"},{"issue":"4","key":"2_CR128","first-page":"33","volume":"8","author":"P Reang","year":"2006","unstructured":"Reang P, Gupta M, Kohli K (2006) Biological response modifiers in cancer. Med Gen Med 8(4):33","journal-title":"Med Gen Med"},{"issue":"4","key":"2_CR129","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0889-8588(05)70244-6","volume":"15","author":"LL Worth","year":"2001","unstructured":"Worth LL, Jeha SS, Kleinerman ES (2001), Biologic response modifiers in pediatric cancer. Hematol Oncol Clin North Am 15(4):723\u2013740, 9","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"2_CR130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00262-008-0598-y","volume":"58","author":"T Zhang","year":"2009","unstructured":"Zhang T, Herlyn D (2009) Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer. Cancer Immunol Immunother 58(4):475\u2013492","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"2_CR131","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/15476910801897920","volume":"5","author":"R Ponce","year":"2008","unstructured":"Ponce R (2008) Adverse consequences of immunostimulation. J Immunotoxicol 5(1):33\u201341","journal-title":"J Immunotoxicol"},{"issue":"11","key":"2_CR132","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/cncr.22666","volume":"109","author":"PI Rafailidis","year":"2007","unstructured":"Rafailidis PI et al (2007) Infectious complications of monoclonal antibodies used in cancer therapy: a systematic review of the evidence from randomized controlled trials. Cancer 109(11):2182\u20132189","journal-title":"Cancer"},{"issue":"3","key":"2_CR133","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/10428190902730219","volume":"50","author":"S Aksoy","year":"2009","unstructured":"Aksoy S et al (2009) Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis. Leuk Lymphoma 50(3):357\u2013365","journal-title":"Leuk Lymphoma"},{"issue":"11(13)","key":"2_CR134","first-page":"11","volume":"16","author":"RN Schwartz","year":"2002","unstructured":"Schwartz RN, Stover L, Dutcher J (2002) Managing toxicities of high-dose interleukin-2. Oncology 16(11(13)):11\u201320 (Williston Park)","journal-title":"Oncology"},{"issue":"3","key":"2_CR135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1017\/S0022172400023615","volume":"72","author":"D Waaij van der","year":"1974","unstructured":"van der Waaij D, Berghuis JM (1974) Determination of the colonization resistance of the digestive tract of individual mice. J Hyg (Lond) 72(3):379\u2013387","journal-title":"J Hyg (Lond)"},{"issue":"21","key":"2_CR136","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM196911202812101","volume":"281","author":"WG Johanson","year":"1969","unstructured":"Johanson WG, Pierce AK, Sanford JP (1969) Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med 281(21):1137\u20131140","journal-title":"N Engl J Med"},{"issue":"4","key":"2_CR137","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM199401273300406","volume":"330","author":"CP Kelly","year":"1994","unstructured":"Kelly CP, Pothoulakis C, LaMont JT (1994) Clostridium difficile colitis. N Engl J Med 330(4):257\u2013262","journal-title":"N Engl J Med"},{"key":"2_CR138","doi-asserted-by":"crossref","unstructured":"Gaskins HR et al (2008) Impact of the intestinal microbiota on the development of mucosal defense. Clin Infect Dis 46(2): S80\u2013S86; discussion S144\u2013S151","DOI":"10.1086\/523336"},{"issue":"10","key":"2_CR139","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1158\/1055-9965.EPI-08-0792","volume":"17","author":"JW Lampe","year":"2008","unstructured":"Lampe JW (2008) The Human Microbiome Project: getting to the guts of the matter in cancer epidemiology. Cancer Epidemiol Biomarkers Prev 17(10):2523\u20132524","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2_CR140","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/1471-2164-10-380","volume":"10","author":"JJ Mans","year":"2009","unstructured":"Mans JJ et al (2009) The degree of microbiome complexity influences the epithelial response to infection. BMC Genom 10:380","journal-title":"BMC Genom"},{"issue":"2","key":"2_CR141","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11908-008-0017-8","volume":"10","author":"S Rabizadeh","year":"2008","unstructured":"Rabizadeh S, Sears C (2008) New horizons for the infectious diseases specialist: how gut microflora promote health and disease. Curr Infect Dis Rep 10(2):92\u201398","journal-title":"Curr Infect Dis Rep"},{"issue":"11","key":"2_CR142","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/BF01967791","volume":"11","author":"C Tancrede","year":"1992","unstructured":"Tancrede C (1992) Role of human microflora in health and disease. Eur J Clin Microbiol Infect Dis 11(11):1012\u20131015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"2_CR143","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1469-0691.2007.01841.x","volume":"14","author":"E Raum","year":"2008","unstructured":"Raum E et al (2008) Changes in Escherichia coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany. Clin Microbiol Infect 14(1):41\u201348","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"2_CR144","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1086\/599346","volume":"49","author":"MJ Vliet van","year":"2009","unstructured":"van Vliet MJ et al (2009) Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin Infect Dis 49(2):262\u2013270","journal-title":"Clin Infect Dis"},{"key":"2_CR145","unstructured":"Wade JC, Schimpff SC (1988) Epidemiology and prevention of infection in the compromised host. In: Rubin RH, Young LS (eds) Clinical approach to infection in the compromised host. Plenum Medical, New York, pp 5\u201340"},{"issue":"1","key":"2_CR146","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9343(76)90026-7","volume":"61","author":"J Aisner","year":"1976","unstructured":"Aisner J et al (1976) Torulopsis glabrata infections in patients with cancer. Increasing incidence and relationship to colonization. Am J Med 61(1):23\u201328","journal-title":"Am J Med"},{"issue":"6","key":"2_CR147","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/clinids\/17.6.1018","volume":"17","author":"DJ Boken","year":"1993","unstructured":"Boken DJ, Swindells S, Rinaldi MG (1993) Fluconazole-resistant Candida albicans. Clin Infect Dis 17(6):1018\u20131021","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2_CR148","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1128\/AAC.35.11.2302","volume":"35","author":"P Fan-Havard","year":"1991","unstructured":"Fan-Havard P et al (1991) Development of resistance in candida isolates from patients receiving prolonged antifungal therapy. Antimicrob Agents Chemother 35(11):2302\u20132305","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"2_CR149","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1093\/clinids\/14.Supplement_1.S120","volume":"14","author":"F Meunier","year":"1992","unstructured":"Meunier F, Aoun M, Bitar N (1992) Candidemia in immunocompromised patients. Clin Infect Dis 14(Suppl 1):S120\u2013S125","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2_CR150","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/JCM.24.4.581-584.1986","volume":"24","author":"WG Merz","year":"1986","unstructured":"Merz WG et al (1986) Increased incidence of fungemia caused by Candida krusei. J Clin Microbiol 24(4):581\u2013584","journal-title":"J Clin Microbiol"},{"issue":"18","key":"2_CR151","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","volume":"325","author":"JR Wingard","year":"1991","unstructured":"Wingard JR et al (1991) Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 325(18):1274\u20131277","journal-title":"N Engl J Med"},{"issue":"12","key":"2_CR152","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.7326\/0003-4819-119-12-199312150-00003","volume":"119","author":"JS Groeger","year":"1993","unstructured":"Groeger JS et al (1993) Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 119(12):1168\u20131174","journal-title":"Ann Intern Med"},{"key":"2_CR153","doi-asserted-by":"crossref","unstructured":"Al Wohoush I, Chaftari AM, Raad I (2011) Catheter-related infections in cancer patients. In: Safdar A (ed) Principles and practice of cancer infectious diseases. Springer, New York, pp 113\u2013122","DOI":"10.1007\/978-1-60761-644-3_10"},{"key":"2_CR154","unstructured":"Beekmann SE, Henderson DK (2010) Infections caused by percutaneous intravascular devices. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Doublas, and Bennett\u2019s principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp 3697\u20133716"},{"issue":"2","key":"2_CR155","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/NAN.0b013e31820b8a3e","volume":"34","author":"J Segreti","year":"2009","unstructured":"Segreti J et al (2009) Consensus conference on prevention of central line-associated bloodstream infections. J Infus Nurs 34(2):126\u2013133","journal-title":"J Infus Nurs"},{"issue":"10","key":"2_CR156","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1200\/JCO.2012.45.5733","volume":"31","author":"CA Schiffer","year":"2013","unstructured":"Schiffer CA et al (2013) Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 31(10):1357\u20131370","journal-title":"J Clin Oncol"},{"issue":"9","key":"2_CR157","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1093\/cid\/cir257","volume":"52","author":"NP O\u2019Grady","year":"2011","unstructured":"O\u2019Grady NP et al (2011) Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52(9):e162\u2013e193","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2_CR158","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1001\/archinte.1986.00360220101019","volume":"146","author":"JH Tenney","year":"1986","unstructured":"Tenney JH et al (1986) Adherent microorganisms on lumenal surfaces of long-term intravenous catheters. Importance of Staphylococcus epidermidis in patients with cancer. Arch Intern Med 146(10):1949\u20131954","journal-title":"Arch Intern Med"},{"issue":"18","key":"2_CR159","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM199305063281808","volume":"328","author":"PA Pizzo","year":"1993","unstructured":"Pizzo PA (1993) Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 328(18):1323\u20131332","journal-title":"N Engl J Med"},{"issue":"4","key":"2_CR160","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3109\/00365548.2010.544669","volume":"43","author":"EJ Joo","year":"2011","unstructured":"Joo EJ et al (2011) Clinical outcome of catheter salvage in neutropenic cancer patients with catheter-related infection. Scand J Infect Dis 43(4):258\u2013263","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"2_CR161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA et al (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49(1):1\u201345","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2_CR162","doi-asserted-by":"crossref","first-page":"707","DOI":"10.7326\/0003-4819-77-5-707","volume":"77","author":"SC Schimpff","year":"1972","unstructured":"Schimpff SC et al (1972) Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Ann Intern Med 77(5):707\u2013714","journal-title":"Ann Intern Med"},{"issue":"2","key":"2_CR163","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/infdis\/138.2.227","volume":"138","author":"SN Schwartz","year":"1978","unstructured":"Schwartz SN et al (1978) Sources of gram-negative bacilli colonizing the tracheae of intubated patients. J Infect Dis 138(2):227\u2013331","journal-title":"J Infect Dis"},{"issue":"2","key":"2_CR164","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biologicals.2009.01.002","volume":"37","author":"JP Allain","year":"2009","unstructured":"Allain JP et al (2009) Transfusion-transmitted infectious diseases. Biologicals 37(2):71\u201377","journal-title":"Biologicals"},{"issue":"1","key":"2_CR165","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.seminhematol.2006.09.016","volume":"44","author":"HJ Alter","year":"2007","unstructured":"Alter HJ, Stramer SL, Dodd RY (2007) Emerging infectious diseases that threaten the blood supply. Semin Hematol 44(1):32\u201341","journal-title":"Semin Hematol"},{"issue":"4","key":"2_CR166","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1423-0410.2009.01134.x","volume":"97","author":"JS Rachoin","year":"2009","unstructured":"Rachoin JS et al (2009) Microbiology, time course and clinical characteristics of infection in critically ill patients receiving packed red blood cell transfusion. Vox Sang 97(4):294\u2013302","journal-title":"Vox Sang"},{"issue":"12","key":"2_CR167","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.7326\/0003-4819-110-12-1001","volume":"110","author":"KM Gottesdiener","year":"1989","unstructured":"Gottesdiener KM (1989) Transplanted infections: donor-to-host transmission with the allograft. Ann Intern Med 110(12):1001\u20131016","journal-title":"Ann Intern Med"},{"issue":"6722","key":"2_CR168","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/bmj.300.6722.450","volume":"300","author":"JA Barbara","year":"1990","unstructured":"Barbara JA, Contreras M (1990) ABC of transfusion. Infectious complications of blood transfusion: viruses. BMJ 300(6722):450\u2013453","journal-title":"BMJ"},{"issue":"10","key":"2_CR169","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1182\/blood-2002-10-3143","volume":"101","author":"WG Nichols","year":"2003","unstructured":"Nichols WG et al (2003) Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products. Blood 101(10):4195\u20134200","journal-title":"Blood"},{"issue":"22","key":"2_CR170","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJM198911303212202","volume":"321","author":"HJ Alter","year":"1989","unstructured":"Alter HJ et al (1989) Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 321(22):1494\u20131500","journal-title":"N Engl J Med"},{"issue":"4","key":"2_CR171","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0891-5520(20)30312-3","volume":"3","author":"KH Mayer","year":"1989","unstructured":"Mayer KH, Opal SM (1989) Unusual nosocomial pathogens. Infect Dis Clin North Am 3(4):883\u2013899","journal-title":"Infect Dis Clin North Am"},{"issue":"1","key":"2_CR172","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/0003-4819-116-1-55","volume":"116","author":"MH Sayers","year":"1992","unstructured":"Sayers MH et al (1992) Reducing the risk for transfusion-transmitted cytomegalovirus infection. Ann Intern Med 116(1):55\u201362","journal-title":"Ann Intern Med"},{"issue":"1","key":"2_CR173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000466255","volume":"47","author":"JP Soulier","year":"1984","unstructured":"Soulier JP (1984) Diseases transmissible by blood transfusion. Vox Sang 47(1):1\u20136","journal-title":"Vox Sang"},{"issue":"5","key":"2_CR174","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/0003-4819-96-5-601","volume":"96","author":"M Wittner","year":"1982","unstructured":"Wittner M et al (1982) Successful chemotherapy of transfusion babesiosis. Ann Intern Med 96(5):601\u2013604","journal-title":"Ann Intern Med"},{"issue":"8391","key":"2_CR175","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(84)91891-9","volume":"1","author":"E Tabor","year":"1984","unstructured":"Tabor E, Gerety RJ (1984) Five cases of Pseudomonas sepsis transmitted by blood transfusions. Lancet 1(8391):1403","journal-title":"Lancet"},{"issue":"11","key":"2_CR176","first-page":"1040","volume":"109","author":"DC Wright","year":"1985","unstructured":"Wright DC et al (1985) Fatal Yersinia enterocolitica sepsis after blood transfusion. Arch Pathol Lab Med 109(11):1040\u20131042","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"2_CR177","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1046\/j.1537-2995.1993.331194082380.x","volume":"33","author":"R Yomtovian","year":"1993","unstructured":"Yomtovian R et al (1993) A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets. Transfusion 33(11):902\u2013909","journal-title":"Transfusion"},{"key":"2_CR178","unstructured":"Rolston KV (2009) Risk assessment and the management of neutropenic fever. In: Yeung SJ, Escalante CP, Gagel RF (eds) Medical care of cancer patients. People\u2019s Medical Publishing House, Shelton, pp 133\u2013138"},{"issue":"4","key":"2_CR179","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/1097-0142(197804)41:4<1610::AID-CNCR2820410452>3.0.CO;2-B","volume":"41","author":"GP Bodey","year":"1978","unstructured":"Bodey GP et al (1978) Fever and infection in leukemic patients: a study of 494 consecutive patients. Cancer 41(4):1610\u20131622","journal-title":"Cancer"},{"issue":"4","key":"2_CR180","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s12032-009-9330-9","volume":"27","author":"A Gupta","year":"2010","unstructured":"Gupta A et al (2010) Infections in acute myeloid leukemia: an analysis of 382 febrile episodes. Med Oncol 27(4):1037\u20131045","journal-title":"Med Oncol"},{"issue":"2","key":"2_CR181","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF02796205","volume":"17","author":"R Jagarlamudi","year":"2000","unstructured":"Jagarlamudi R et al (2000) Infections in acute leukemia: an analysis of 240 febrile episodes. Med Oncol 17(2):111\u2013116","journal-title":"Med Oncol"},{"issue":"Suppl 1","key":"2_CR182","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1007\/s11739-010-0456-8","volume":"5","author":"F Menichetti","year":"2010","unstructured":"Menichetti F (2010) Infectious complications in neutropenic cancer patients. Intern Emerg Med 5(Suppl 1):S21\u2013S25","journal-title":"Intern Emerg Med"},{"issue":"Suppl 4","key":"2_CR183","doi-asserted-by":"crossref","first-page":"S246","DOI":"10.1086\/427331","volume":"40","author":"KV Rolston","year":"2005","unstructured":"Rolston KV (2005) Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia. Clin Infect Dis 40(Suppl 4):S246\u2013S252","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2_CR184","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0025-7125(16)31284-6","volume":"61","author":"SC Schimpff","year":"1977","unstructured":"Schimpff SC (1977) Therapy of infection in patients with granulocytopenia. Med Clin North Am 61(5):1101\u20131118","journal-title":"Med Clin North Am"},{"issue":"2","key":"2_CR185","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0002-9343(86)90257-3","volume":"81","author":"JE Karp","year":"1986","unstructured":"Karp JE et al (1986) Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia. Am J Med 81(2):237\u2013242","journal-title":"Am J Med"},{"issue":"1","key":"2_CR186","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/archinte.1983.00350010034007","volume":"143","author":"DJ Winston","year":"1983","unstructured":"Winston DJ et al (1983) Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med 143(1):32\u201336","journal-title":"Arch Intern Med"},{"issue":"6","key":"2_CR187","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF01738551","volume":"61","author":"M Arning","year":"1990","unstructured":"Arning M et al (1990) Septicemia due to Streptococcus mitis in neutropenic patients with acute leukemia. Blut 61(6):364\u2013368","journal-title":"Blut"},{"issue":"5073","key":"2_CR188","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1126\/science.257.5073.1064","volume":"257","author":"HC Neu","year":"1992","unstructured":"Neu HC (1992) The crisis in antibiotic resistance. Science 257(5073):1064\u20131073","journal-title":"Science"},{"issue":"5","key":"2_CR189","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/infdis\/164.5.907","volume":"164","author":"JW Sanders","year":"1991","unstructured":"Sanders JW, Powe NR, Moore RD (1991) Ceftazidime monotherapy for empiric treatment of febrile neutropenic patients: a meta-analysis. J Infect Dis 164(5):907\u2013916","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"2_CR190","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1093\/clinids\/14.Supplement_1.S43","volume":"14","author":"E Anaissie","year":"1992","unstructured":"Anaissie E (1992) Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 14(Suppl 1):S43\u2013S53","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2_CR191","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0002-9343(82)90334-5","volume":"73","author":"MW DeGregorio","year":"1982","unstructured":"DeGregorio MW et al (1982) Fungal infections in patients with acute leukemia. Am J Med 73(4):543\u2013548","journal-title":"Am J Med"},{"issue":"4","key":"2_CR192","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0002-9343(81)90208-4","volume":"71","author":"BD Fisher","year":"1981","unstructured":"Fisher BD et al (1981) Invasive aspergillosis. Progress in early diagnosis and treatment. Am J Med 71(4):571\u2013577","journal-title":"Am J Med"},{"issue":"3","key":"2_CR193","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-100-3-345","volume":"100","author":"SL Gerson","year":"1984","unstructured":"Gerson SL et al (1984) Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 100(3):345\u2013351","journal-title":"Ann Intern Med"},{"issue":"4","key":"2_CR194","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/clinids\/14.4.875","volume":"14","author":"JA Lecciones","year":"1992","unstructured":"Lecciones JA et al (1992) Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 14(4):875\u2013883","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2_CR195","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9343(81)90162-5","volume":"71","author":"F Meunier-Carpentier","year":"1981","unstructured":"Meunier-Carpentier F, Kiehn TE, Armstrong D (1981) Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality. Am J Med 71(3):363\u2013370","journal-title":"Am J Med"},{"issue":"2","key":"2_CR196","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jinf.2009.06.002","volume":"59","author":"R Ben-Ami","year":"2009","unstructured":"Ben-Ami R et al (2009) A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response. J Infect 59(2):134\u2013138","journal-title":"J Infect"},{"issue":"4","key":"2_CR197","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0750-7658(01)00374-4","volume":"20","author":"P Eggimann","year":"2001","unstructured":"Eggimann P, Pittet D (2001) Candidiasis among non-neutropenic patients: from colonization to infection. Ann Fr Anesth Reanim 20(4):382\u2013388","journal-title":"Ann Fr Anesth Reanim"},{"issue":"2","key":"2_CR198","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11046-004-5495-0","volume":"159","author":"A Shaukat","year":"2005","unstructured":"Shaukat A et al (2005) Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics. Mycopathologia 159(2):181\u2013188","journal-title":"Mycopathologia"},{"issue":"2","key":"2_CR199","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF01967060","volume":"11","author":"G Bodey","year":"1992","unstructured":"Bodey G et al (1992) Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 11(2):99\u2013109","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"2_CR200","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJM198603203141205","volume":"314","author":"L Corey","year":"1986","unstructured":"Corey L, Spear PG (1986) Infections with herpes simplex viruses (2). N Engl J Med 314(12):749\u2013757","journal-title":"N Engl J Med"},{"issue":"11","key":"2_CR201","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM198603133141105","volume":"314","author":"L Corey","year":"1986","unstructured":"Corey L, Spear PG (1986) Infections with herpes simplex viruses (1). N Engl J Med 314(11):686\u2013691","journal-title":"N Engl J Med"},{"issue":"9","key":"2_CR202","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jama.1992.03480090085032","volume":"267","author":"LJ Kaplan","year":"1992","unstructured":"Kaplan LJ et al (1992) Severe measles in immunocompromised patients. JAMA 267(9):1237\u20131241","journal-title":"JAMA"},{"issue":"3","key":"2_CR203","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/infdis\/153.3.478","volume":"153","author":"JD Meyers","year":"1986","unstructured":"Meyers JD, Flournoy N, Thomas ED (1986) Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 153(3):478\u2013488","journal-title":"J Infect Dis"},{"issue":"7","key":"2_CR204","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/1097-0142(19821001)50:7<1262::AID-CNCR2820500707>3.0.CO;2-F","volume":"50","author":"KH Rand","year":"1982","unstructured":"Rand KH, Kramer B, Johnson AC (1982) Cancer chemotherapy associated symptomatic stomatitis: role of Herpes simplex virus (HSV). Cancer 50(7):1262\u20131265","journal-title":"Cancer"},{"issue":"2","key":"2_CR205","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/0003-4819-108-2-221","volume":"108","author":"SE Straus","year":"1988","unstructured":"Straus SE et al (1988) NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Intern Med 108(2):221\u2013237","journal-title":"Ann Intern Med"},{"issue":"5","key":"2_CR206","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0002-9343(80)90262-4","volume":"68","author":"JM Zahradnik","year":"1980","unstructured":"Zahradnik JM, Spencer MJ, Porter DD (1980) Adenovirus infection in the immunocompromised patient. Am J Med 68(5):725\u2013732","journal-title":"Am J Med"},{"issue":"7","key":"2_CR207","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00520-005-0898-0","volume":"14","author":"E Toussaint","year":"2006","unstructured":"Toussaint E et al (2006) Causes of fever in cancer patients (prospective study over 477 episodes). Support Care Cancer 14(7):763\u2013769","journal-title":"Support Care Cancer"},{"issue":"5","key":"2_CR208","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1590\/S1516-31802000000500004","volume":"118","author":"E Velasco","year":"2000","unstructured":"Velasco E et al (2000) Epidemiology of bloodstream infections at a cancer center. Sao Paulo Med J 118(5):131\u2013138","journal-title":"Sao Paulo Med J"},{"issue":"5","key":"2_CR209","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0002-9343(75)90230-2","volume":"59","author":"SC Schimpff","year":"1975","unstructured":"Schimpff SC et al (1975) Infections in 92 splenectomized patients with Hodgkin\u2019s disease. A clinical review. Am J Med 59(5):695\u2013701","journal-title":"Am J Med"},{"issue":"1","key":"2_CR210","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2141.2001.02487.x","volume":"112","author":"AB Fassas","year":"2001","unstructured":"Fassas AB et al (2001) Cytomegalovirus infection and non-neutropenic fever after autologous stem cell transplantation: high rates of reactivation in patients with multiple myeloma and lymphoma. Br J Haematol 112(1):237\u2013241","journal-title":"Br J Haematol"},{"issue":"10","key":"2_CR211","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4065\/75.10.1039","volume":"75","author":"S Tsiodras","year":"2000","unstructured":"Tsiodras S et al (2000) Infection and immunity in chronic lymphocytic leukemia. Mayo Clin Proc 75(10):1039\u20131054","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"2_CR212","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.seminoncol.2005.12.013","volume":"33","author":"PD Wadhwa","year":"2006","unstructured":"Wadhwa PD, Morrison VA (2006) Infectious complications of chronic lymphocytic leukemia. Semin Oncol 33(2):240\u2013249","journal-title":"Semin Oncol"},{"issue":"1","key":"2_CR213","first-page":"98","volume":"25","author":"VA Morrison","year":"1998","unstructured":"Morrison VA (1998) The infectious complications of chronic lymphocytic leukemia. Semin Oncol 25(1):98\u2013106","journal-title":"Semin Oncol"},{"issue":"5","key":"2_CR214","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3816\/CLM.2009.n.071","volume":"9","author":"VA Morrison","year":"2009","unstructured":"Morrison VA (2009) Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis. Clin Lymphoma Myeloma 9(5):365\u2013370","journal-title":"Clin Lymphoma Myeloma"},{"issue":"1","key":"2_CR215","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3816\/CLML.2010.n.009","volume":"10","author":"A D\u2019Souza","year":"2010","unstructured":"D\u2019Souza A et al (2010) Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia: a report of three cases and review of the literature. Clin Lymphoma Myeloma Leuk 10(1):E1\u2013E9","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"2_CR216","first-page":"282","volume":"13","author":"DR Jacobson","year":"1986","unstructured":"Jacobson DR, Zolla-Pazner S (1986) Immunosuppression and infection in multiple myeloma. Semin Oncol 13(3):282\u2013290","journal-title":"Semin Oncol"},{"issue":"6","key":"2_CR217","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0002-9343(87)90236-1","volume":"82","author":"MI Miller","year":"1987","unstructured":"Miller MI, Hoppmann RA, Pisko EJ (1987) Multiple myeloma presenting with primary meningococcal arthritis. Am J Med 82(6):1257\u20131258","journal-title":"Am J Med"},{"issue":"3","key":"2_CR218","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1128\/JCM.21.3.464-466.1985","volume":"21","author":"E Wachter","year":"1985","unstructured":"Wachter E et al (1985) Neisseria meningitidis serogroup 29E (Z\u2032) septicemia in a patient with far advanced multiple myeloma (plasma cell leukemia). J Clin Microbiol 21(3):464\u2013466","journal-title":"J Clin Microbiol"},{"issue":"2","key":"2_CR219","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0891-5520(05)70151-3","volume":"15","author":"F Paradisi","year":"2001","unstructured":"Paradisi F, Corti G, Cinelli R (2001) Infections in multiple myeloma. Infect Dis Clin North Am 15(2):373\u2013384, 7\u20138","journal-title":"Infect Dis Clin North Am"},{"issue":"8","key":"2_CR220","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/605664","volume":"49","author":"M Nucci","year":"2009","unstructured":"Nucci M, Anaissie E (2009) Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents. Clin Infect Dis 49(8):1211\u20131225","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2_CR221","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1600-0609.2009.01259.x","volume":"83","author":"G Damaj","year":"2009","unstructured":"Damaj G et al (2009) Risk factors for severe infection in patients with hairy cell leukemia: a long-term study of 73 patients. Eur J Haematol 83(3):246\u2013250","journal-title":"Eur J Haematol"},{"issue":"3","key":"2_CR222","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ajh.10267","volume":"72","author":"YM Audeh","year":"2003","unstructured":"Audeh YM et al (2003) Hairy cell leukemia with concurrent cryptococcus infection. Am J Hematol 72(3):223\u2013224","journal-title":"Am J Hematol"},{"issue":"7","key":"2_CR223","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0145-2126(95)00014-F","volume":"19","author":"R Goyal","year":"1995","unstructured":"Goyal R et al (1995) Hairy cell leukemia\u2013an unusual presentation. Leuk Res 19(7):485\u2013487","journal-title":"Leuk Res"},{"issue":"5","key":"2_CR224","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/0002-9343(80)90259-4","volume":"68","author":"PA Mackowiak","year":"1980","unstructured":"Mackowiak PA et al (1980) Infections of hairy cell leukemia. Clinical evidence of a pronounced defect in cell-mediated immunity. Am J Med 68(5):718\u2013724","journal-title":"Am J Med"},{"issue":"3","key":"2_CR225","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11864-001-0035-3","volume":"2","author":"L Savoie","year":"2001","unstructured":"Savoie L, Johnston JB (2001) Hairy cell leukemia. Curr Treat Options Oncol 2(3):217\u2013224","journal-title":"Curr Treat Options Oncol"},{"issue":"5","key":"2_CR226","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0002-9343(86)90634-0","volume":"80","author":"C Bennett","year":"1986","unstructured":"Bennett C, Vardiman J, Golomb H (1986) Disseminated atypical mycobacterial infection in patients with hairy cell leukemia. Am J Med 80(5):891\u2013896","journal-title":"Am J Med"},{"issue":"4","key":"2_CR227","first-page":"349","volume":"40","author":"WT Huang","year":"2007","unstructured":"Huang WT et al (2007) Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients. J Microbiol Immunol Infect 40(4):349\u2013354","journal-title":"J Microbiol Immunol Infect"},{"issue":"6","key":"2_CR228","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/clinids\/14.6.1201","volume":"14","author":"LS Elting","year":"1992","unstructured":"Elting LS, Bodey GP, Keefe BH (1992) Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis 14(6):1201\u20131207","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2_CR229","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/JCM.44.1.160-165.2006","volume":"44","author":"XY Han","year":"2006","unstructured":"Han XY, Kamana M, Rolston KV (2006) Viridans streptococci isolated by culture from blood of cancer patients: clinical and microbiologic analysis of 50 cases. J Clin Microbiol 44(1):160\u2013165","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2_CR230","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/clinids\/13.1.139","volume":"13","author":"RL Harvey","year":"1991","unstructured":"Harvey RL, Sunstrum JC (1991) Rhodococcus equi infection in patients with and without human immunodeficiency virus infection. Rev Infect Dis 13(1):139\u2013145","journal-title":"Rev Infect Dis"},{"issue":"3","key":"2_CR231","doi-asserted-by":"crossref","first-page":"e32945","DOI":"10.1371\/journal.pone.0032945","volume":"7","author":"F Al Akhrass","year":"2012","unstructured":"Al Akhrass F et al (2012) Rhodococcus bacteremia in cancer patients is mostly catheter related and associated with biofilm formation. PLoS One 7(3):e32945","journal-title":"PLoS One"},{"issue":"6","key":"2_CR232","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/clinids\/12.6.997","volume":"12","author":"N Khardori","year":"1990","unstructured":"Khardori N et al (1990) Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev Infect Dis 12(6):997\u20131003","journal-title":"Rev Infect Dis"},{"issue":"3","key":"2_CR233","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s15010-010-0023-2","volume":"38","author":"M Yeshurun","year":"2010","unstructured":"Yeshurun M et al (2010) Clinical characteristics of Stenotrophomonas maltophilia infection in hematopoietic stem cell transplantation recipients: a single center experience. Infection 38(3):211\u2013215","journal-title":"Infection"},{"issue":"3","key":"2_CR234","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s15010-010-0017-0","volume":"38","author":"T Mann","year":"2010","unstructured":"Mann T et al (2010) An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients. Infection 38(3):187\u2013194","journal-title":"Infection"},{"issue":"11","key":"2_CR235","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3201\/eid1011.040127","volume":"10","author":"A Petrucca","year":"2004","unstructured":"Petrucca A et al (2004) Burkholderia cenocepacia vaginal infection in patient with smoldering myeloma and chronic hepatitis C. Emerg Infect Dis 10(11):1957\u20131959","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"2_CR236","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/cncr.20604","volume":"101","author":"G Aisenberg","year":"2004","unstructured":"Aisenberg G, Rolston KV, Safdar A (2004) Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989\u20132003). Cancer 101(9):2134\u20132140","journal-title":"Cancer"},{"issue":"3","key":"2_CR237","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/j.ijid.2008.06.032","volume":"13","author":"SK Chiu","year":"2009","unstructured":"Chiu SK, Chang FY (2009) Pyomyositis caused by extended-spectrum beta-lactamase-producing Escherichia coli in a patient with acute myeloid leukemia. Int J Infect Dis 13(3):e85\u2013e87","journal-title":"Int J Infect Dis"},{"issue":"4","key":"2_CR238","first-page":"182","volume":"110","author":"U Sharma","year":"2011","unstructured":"Sharma U, Schwan WR, Agger WA (2011) Escherichia coli pyomyositis in an immunocompromised host. WMJ 110(4):182\u2013184","journal-title":"WMJ"},{"issue":"3","key":"2_CR239","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1086\/649866","volume":"50","author":"KJ Vigil","year":"2010","unstructured":"Vigil KJ et al (2010) Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis 50(3):374\u2013380","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2_CR240","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF01962067","volume":"11","author":"M Pfaller","year":"1992","unstructured":"Pfaller M, Wenzel R (1992) Impact of the changing epidemiology of fungal infections in the 1990s. Eur J Clin Microbiol Infect Dis 11(4):287\u2013291","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"2_CR241","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/clinids\/13.3.496","volume":"13","author":"TJ Walsh","year":"1991","unstructured":"Walsh TJ et al (1991) Empiric therapy with amphotericin B in febrile granulocytopenic patients. Rev Infect Dis 13(3):496\u2013503","journal-title":"Rev Infect Dis"},{"issue":"4","key":"2_CR242","doi-asserted-by":"crossref","first-page":"539","DOI":"10.7326\/0003-4819-91-4-539","volume":"91","author":"JR Wingard","year":"1979","unstructured":"Wingard JR, Merz WG, Saral R (1979) Candida tropicalis: a major pathogen in immunocompromised patients. Ann Intern Med 91(4):539\u2013543","journal-title":"Ann Intern Med"},{"issue":"20","key":"2_CR243","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1002\/cncr.24507","volume":"115","author":"NV Sipsas","year":"2009","unstructured":"Sipsas NV et al (2009) Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001\u20132007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer 115(20):4745\u20134752","journal-title":"Cancer"},{"issue":"11","key":"2_CR244","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/cncr.23466","volume":"112","author":"R Hachem","year":"2008","unstructured":"Hachem R et al (2008) The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer 112(11):2493\u20132499","journal-title":"Cancer"},{"issue":"1","key":"2_CR245","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(03)00415-2","volume":"57","author":"MC Dahiya","year":"2003","unstructured":"Dahiya MC et al (2003) Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 57(1):79\u201383","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"2_CR246","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00520-010-0892-z","volume":"18","author":"RV Lalla","year":"2010","unstructured":"Lalla RV et al (2010) A systematic review of oral fungal infections in patients receiving cancer therapy. Support Care Cancer 18(8):985\u2013992","journal-title":"Support Care Cancer"},{"issue":"1","key":"2_CR247","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tripleo.2003.09.008","volume":"97","author":"SW Redding","year":"2004","unstructured":"Redding SW et al (2004) Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97(1):47\u201352","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"2_CR248","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0714.2010.00937.x","volume":"40","author":"S Schelenz","year":"2011","unstructured":"Schelenz S et al (2011) Epidemiology of oral yeast colonization and infection in patients with hematological malignancies, head neck and solid tumors. J Oral Pathol Med 40(1):83\u201389","journal-title":"J Oral Pathol Med"},{"issue":"4","key":"2_CR249","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0891-5520(20)30311-1","volume":"3","author":"E Anaissie","year":"1989","unstructured":"Anaissie E, Bodey GP (1989) Nosocomial fungal infections. Old problems and new challenges. Infect Dis Clin North Am 3(4):867\u2013882","journal-title":"Infect Dis Clin North Am"},{"issue":"7","key":"2_CR250","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/cncr.20554","volume":"101","author":"RY Hachem","year":"2004","unstructured":"Hachem RY et al (2004) Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies. Cancer 101(7):1594\u20131600","journal-title":"Cancer"},{"issue":"2","key":"2_CR251","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1473-3099(10)70218-8","volume":"11","author":"MH Miceli","year":"2011","unstructured":"Miceli MH, Diaz JA, Lee SA (2011) Emerging opportunistic yeast infections. Lancet Infect Dis 11(2):142\u2013151","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"2_CR252","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/JCM.01747-08","volume":"47","author":"MA Pfaller","year":"2009","unstructured":"Pfaller MA et al (2009) Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 47(1):117\u2013123","journal-title":"J Clin Microbiol"},{"issue":"6","key":"2_CR253","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0190-9622(86)70121-7","volume":"14","author":"DC Kalter","year":"1986","unstructured":"Kalter DC et al (1986) Genital white piedra: epidemiology, microbiology, and therapy. J Am Acad Dermatol 14(6):982\u2013993","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"2_CR254","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/archderm.1993.01680290092014","volume":"129","author":"GT Nahass","year":"1993","unstructured":"Nahass GT et al (1993) Disseminated infection with Trichosporon beigelii. Report of a case and review of the cutaneous and histologic manifestations. Arch Dermatol 129(8):1020\u20131023","journal-title":"Arch Dermatol"},{"issue":"4","key":"2_CR255","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00005792-198607000-00005","volume":"65","author":"TJ Walsh","year":"1986","unstructured":"Walsh TJ et al (1986) Trichosporonosis in patients with neoplastic disease. Medicine 65(4):268\u2013279 (Baltimore)","journal-title":"Medicine"},{"issue":"Suppl 1","key":"2_CR256","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dkq437","volume":"66","author":"L Pagano","year":"2011","unstructured":"Pagano L et al (2011) Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother 66(Suppl 1):i5\u201314","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"2_CR257","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jinf.2010.01.010","volume":"60","author":"M Campo","year":"2010","unstructured":"Campo M, Lewis RE, Kontoyiannis DP (2010) Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998\u20132009. J Infect 60(5):331\u2013337","journal-title":"J Infect"},{"issue":"6","key":"2_CR258","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/clinids\/13.6.1077","volume":"13","author":"AS Gamis","year":"1991","unstructured":"Gamis AS et al (1991) Disseminated infection with Fusarium in recipients of bone marrow transplants. Rev Infect Dis 13(6):1077\u20131088","journal-title":"Rev Infect Dis"},{"issue":"10","key":"2_CR259","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1128\/AAC.00286-10","volume":"54","author":"O Lortholary","year":"2010","unstructured":"Lortholary O et al (2010) International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. Antimicrob Agents Chemother 54(10):4446\u20134450","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"2_CR260","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1007\/BF01961136","volume":"11","author":"M Nucci","year":"1992","unstructured":"Nucci M et al (1992) Three cases of infection with Fusarium species in neutropenic patients. Eur J Clin Microbiol Infect Dis 11(12):1160\u20131162","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"2_CR261","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/497832","volume":"41","author":"A Enache-Angoulvant","year":"2005","unstructured":"Enache-Angoulvant A, Hennequin C (2005) Invasive Saccharomyces infection: a comprehensive review. Clin Infect Dis 41(11):1559\u20131568","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2_CR262","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1086\/597400","volume":"48","author":"R Ben-Ami","year":"2009","unstructured":"Ben-Ami R et al (2009) Phaeohyphomycosis in a tertiary care cancer center. Clin Infect Dis 48(8):1033\u20131041","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2_CR263","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.tim.2011.07.010","volume":"19","author":"V Chaturvedi","year":"2011","unstructured":"Chaturvedi V, Chaturvedi S (2011) Cryptococcus gattii: a resurgent fungal pathogen. Trends Microbiol 19(11):564\u2013571","journal-title":"Trends Microbiol"},{"issue":"2","key":"2_CR264","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3201\/eid1702.101020","volume":"17","author":"L MacDougall","year":"2011","unstructured":"MacDougall L et al (2011) Risk factors for Cryptococcus gattii infection, British Columbia, Canada. Emerg Infect Dis 17(2):193\u2013199","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"2_CR265","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2010","unstructured":"Perfect JR et al (2010) Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 50(3):291\u2013322","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2_CR266","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.idc.2010.01.007","volume":"24","author":"D Kumar","year":"2010","unstructured":"Kumar D, Humar A (2010) Respiratory viral infections in transplant and oncology patients. Infect Dis Clin North Am 24(2):395\u2013412","journal-title":"Infect Dis Clin North Am"},{"issue":"4","key":"2_CR267","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/QCO.0b013e328355660b","volume":"25","author":"A Kaltsas","year":"2012","unstructured":"Kaltsas A, Sepkowitz K (2012) Community acquired respiratory and gastrointestinal viral infections: challenges in the immunocompromised host. Curr Opin Infect Dis 25(4):423\u2013430","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"2_CR268","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrclinonc.2012.1","volume":"9","author":"HA Torres","year":"2012","unstructured":"Torres HA, Davila M (2012) Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer. Nat Rev Clin Oncol 9(3):156\u2013166","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"2_CR269","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1086\/605630","volume":"49","author":"RR Roberts","year":"2009","unstructured":"Roberts RR et al (2009) Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis 49(8):1175\u20131184","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2_CR270","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.bbmt.2010.05.008","volume":"16","author":"M Kamboj","year":"2010","unstructured":"Kamboj M et al (2010) The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Biol Blood Marrow Transplant 16(11):1576\u20131581","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2_CR271","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/cid\/cis550","volume":"55","author":"J Vydra","year":"2012","unstructured":"Vydra J et al (2012) Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 55(6):764\u2013770","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2_CR272","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1086\/519932","volume":"28","author":"G Ghanem","year":"2007","unstructured":"Ghanem G et al (2007) Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Infect Control Hosp Epidemiol 28(9):1054\u20131059","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"2_CR273","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00277-012-1539-6","volume":"92","author":"K Wudhikarn","year":"2013","unstructured":"Wudhikarn K, Gingrich RD, de Magalhaes M (2013) Silverman, Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat. Ann Hematol 92(1):129\u2013131","journal-title":"Ann Hematol"},{"issue":"9","key":"2_CR274","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00520-007-0398-5","volume":"16","author":"PG Morris","year":"2008","unstructured":"Morris PG et al (2008) Emergence of MRSA in positive blood cultures from patients with febrile neutropenia\u2013a cause for concern. Support Care Cancer 16(9):1085\u20131088","journal-title":"Support Care Cancer"},{"issue":"6","key":"2_CR275","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1245\/s10434-010-0923-5","volume":"17","author":"RF Chemaly","year":"2010","unstructured":"Chemaly RF et al (2010) Characteristics and outcomes of methicillin-resistant Staphylococcus aureus surgical-site infections in patients with cancer: a case-control study. Ann Surg Oncol 17(6):1499\u20131506","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"2_CR276","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/PRS.0b013e31828bd377","volume":"131","author":"RG Reish","year":"2013","unstructured":"Reish RG et al (2013) Infection following implant-based reconstruction in 1952 consecutive breast reconstructions: salvage rates and predictors of success. Plast Reconstr Surg 131(6):1223\u20131230","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"2_CR277","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bjoms.2007.12.013","volume":"46","author":"SN Rogers","year":"2008","unstructured":"Rogers SN et al (2008) Which patients are most at risk of methicillin resistant Staphylococcus aureus: a review of admissions to a regional maxillofacial ward between 2001 and 2005. Br J Oral Maxillofac Surg 46(6):439\u2013444","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"2","key":"2_CR278","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/00016480600750018","volume":"127","author":"T Shiomori","year":"2007","unstructured":"Shiomori T et al (2007) Clinical features of head and neck cancer patients with methicillin-resistant Staphylococcus aureus. Acta Otolaryngol 127(2):180\u2013185","journal-title":"Acta Otolaryngol"},{"issue":"9","key":"2_CR279","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1258\/0022215042244732","volume":"118","author":"K Watters","year":"2004","unstructured":"Watters K, O\u2019Dwyer TP, Rowley H (2004) Cost and morbidity of MRSA in head and neck cancer patients: what are the consequences? J Laryngol Otol 118(9):694\u2013699","journal-title":"J Laryngol Otol"},{"issue":"3","key":"2_CR280","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/jac\/dkm514","volume":"61","author":"C Cattaneo","year":"2008","unstructured":"Cattaneo C et al (2008) Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. J Antimicrob Chemother 61(3):721\u2013728","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"2_CR281","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10096-010-1093-x","volume":"30","author":"M Arnan","year":"2011","unstructured":"Arnan M et al (2011) Risk factors for, and clinical relevance of, faecal extended-spectrum beta-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microbiol Infect Dis 30(3):355\u2013360","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"2_CR282","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/dkp411","volume":"65","author":"C Gudiol","year":"2010","unstructured":"Gudiol C et al (2010) Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome. J Antimicrob Chemother 65(2):333\u2013341","journal-title":"J Antimicrob Chemother"},{"key":"2_CR283","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2334-8-80","volume":"8","author":"S Irfan","year":"2008","unstructured":"Irfan S et al (2008) Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study. BMC Infect Dis 8:80","journal-title":"BMC Infect Dis"},{"issue":"6","key":"2_CR284","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1159\/000321018","volume":"56","author":"AN Kunz","year":"2010","unstructured":"Kunz AN, Brook I (2010) Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections. Chemotherapy 56(6):492\u2013500","journal-title":"Chemotherapy"},{"issue":"3","key":"2_CR285","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jac\/dkn514","volume":"63","author":"M Ortega","year":"2009","unstructured":"Ortega M et al (2009) Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J Antimicrob Chemother 63(3):568\u2013574","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"2_CR286","first-page":"439","volume":"110","author":"P Sood","year":"2012","unstructured":"Sood P et al (2012) Emergence of multidrug resistant acinetobacter blood stream infections in febrile neutropenia patients with haematological cancers and bone marrow failure syndromes. J Indian Med Assoc 110(7):439\u2013444","journal-title":"J Indian Med Assoc"},{"issue":"9","key":"2_CR287","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ajic.2009.02.002","volume":"37","author":"KJ Vigil","year":"2009","unstructured":"Vigil KJ et al (2009) Multidrug-resistant Escherichia coli bacteremia in cancer patients. Am J Infect Control 37(9):741\u2013745","journal-title":"Am J Infect Control"}],"container-title":["Cancer Treatment and Research","Infectious Complications in Cancer Patients"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-04220-6_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T20:02:45Z","timestamp":1648756965000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-04220-6_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9783319042190","9783319042206"],"references-count":287,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-04220-6_2","relation":{},"ISSN":["0927-3042"],"issn-type":[{"value":"0927-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"6 April 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}